Cochrane Abstracts
Omega‐3 fatty acid supplementation for cystic fibrosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Omega‐3 Fatty Acid Supplementation for Cystic Fibrosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434623/all/Omega‐3_fatty_acid_supplementation_for_cystic_fibrosis.
Omega‐3 fatty acid supplementation for cystic fibrosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434623/all/Omega‐3_fatty_acid_supplementation_for_cystic_fibrosis. Accessed January 31, 2025.
Omega‐3 fatty acid supplementation for cystic fibrosis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434623/all/Omega‐3_fatty_acid_supplementation_for_cystic_fibrosis
Omega‐3 Fatty Acid Supplementation for Cystic Fibrosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 31]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434623/all/Omega‐3_fatty_acid_supplementation_for_cystic_fibrosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Omega‐3 fatty acid supplementation for cystic fibrosis
ID - 434623
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434623/all/Omega‐3_fatty_acid_supplementation_for_cystic_fibrosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
